$83.23 +3.52 (%) Vertex Pharmaceuticals Inc - NASDAQ

Feb. 12, 2016 | 04:00 PM

Partner Headlines

  1. Vertex Filing For Expanded Kalydeco Label Rejected By FDA

    IBD | Feb. 5, 2016 | 12:48PM EST
  2. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD | Jan. 11, 2016 | 19:05PM EST
  3. Vertex Receives Two EU Approvals for KALYDECO for Cystic Fibrosis

    Benzinga | Nov. 18, 2015 | 04:19AM EST
  4. Valeant Dumps Philidor, Falls

    IBD | Oct. 30, 2015 | 18:13PM EST
  5. Alexion, Vertex Steal Mo Stanley's Eyes From Gilead

    IBD | Oct. 2, 2015 | 12:42PM EST
  6. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD | Oct. 2, 2015 | 08:48AM EST
  7. Wall Street Wobbles as Stocks Try to Rebound

    FoxBusiness | Sep. 29, 2015 | 08:00AM EST
  8. EU panel says yes to key drugs

    IBD | Sep. 25, 2015 | 18:47PM EST
  9. 5 Key Drugs That Just Won EU Endorsements

    IBD | Sep. 25, 2015 | 15:19PM EST
  10. VERTEX PHARMA

    IBD | Jul. 29, 2015 | 18:29PM EST
  11. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  12. Stocks Roll Higher, Trade Mixed

    IBD | Jul. 15, 2015 | 10:58AM EST
  13. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  14. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD | Jul. 9, 2015 | 11:12AM EST
  15. Vertex's Orkambi Approved For CF, Prices On High Side

    IBD | Jul. 2, 2015 | 16:34PM EST
  16. UPDATE: Vertex Release Confirms FDA Approval of ORKAMBI

    Benzinga | Jul. 2, 2015 | 13:47PM EST
  17. Andreas Halvorsen Increases Stake in Esperion Therapeutics

    GuruFocus | Jun. 30, 2015 | 00:18AM EST
  18. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD | Jun. 26, 2015 | 17:28PM EST
  19. Vertex Pharma Offers Data Presentations at ECFS Conference: TRAFFIC, TRANSPORT Extension Study of Lumacaftor Im Combo with Ivacaftor Showed Improvements

    Benzinga | Jun. 11, 2015 | 09:04AM EST
  20. Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Diseases

    Benzinga | Jun. 4, 2015 | 16:02PM EST
  21. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  22. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  23. Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter

    GuruFocus | May. 20, 2015 | 14:16PM EST
  24. Stocks: Quiet Open Ahead Of Fed; Dycom Rockets, Airlines Ruffled

    IBD | May. 20, 2015 | 10:42AM EST
  25. Stocks Open To Quiet Gains; Williams, Pall And Zebra Spike

    IBD | May. 13, 2015 | 10:44AM EST
  26. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 21:22PM EST
  27. Panel OKs cystic fibrosis med

    IBD | May. 12, 2015 | 19:03PM EST
  28. Vertex CF Drug Orkambi Wins FDA Advisory Panel Vote

    IBD | May. 12, 2015 | 17:10PM EST
  29. Stocks Finish Lower; GoDaddy Down After Hours On Earnings

    IBD | May. 12, 2015 | 17:03PM EST
  30. FDA Advisory Panel Vote Inconclusive on Whether Vertex's Lumacaftor Contributes Positively to Orkambi's Effectiveness

    Benzinga | May. 12, 2015 | 15:30PM EST
  31. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  32. Apple Supplier Among 3 Top Earnings Reports Tonight

    IBD | Apr. 29, 2015 | 15:09PM EST
  33. Gilead Sciences

    IBD | Apr. 21, 2015 | 18:48PM EST
  34. Short Sellers Come Back To Biotech Stocks

    Benzinga | Feb. 26, 2015 | 13:25PM EST
  35. Short Sellers Retreat From Biotech Stocks

    Benzinga | Feb. 12, 2015 | 08:23AM EST
  36. Super Bowl Stocks: Seattle's Best Vs. Boston Strong

    IBD | Jan. 31, 2015 | 08:02AM EST
  37. Baird Releases Comments After Vertex Earnings Call

    Benzinga | Jan. 29, 2015 | 15:08PM EST
  38. Alexion Beats Q4 Estimates, Appoints New CEO

    IBD | Jan. 29, 2015 | 13:28PM EST
  39. Maxim Downgrades Vertex Pharmaceuticals After Earnings

    Benzinga | Jan. 29, 2015 | 12:00PM EST
  40. Morning Market Losers

    Benzinga | Jan. 29, 2015 | 10:00AM EST
  41. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 29, 2015 | 08:20AM EST
  42. Vertex Pharmaceuticals Beats Q4 Revenue Expectations

    Benzinga | Jan. 28, 2015 | 17:39PM EST
  43. Earnings Scheduled For January 28, 2015

    Benzinga | Jan. 28, 2015 | 05:02AM EST
  44. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga | Jan. 26, 2015 | 14:34PM EST
  45. Vertex CEO On Company's New Cystic Fibrosis Drug, Pricing Strategy

    Benzinga | Jan. 14, 2015 | 10:40AM EST
  46. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  47. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus | Jan. 6, 2015 | 12:46PM EST
  48. UPDATE: Barclays Capital Initiates Coverage On Vertex Pharmaceuticals On Leading Position In CF Market

    Benzinga | Jan. 6, 2015 | 10:24AM EST
  49. BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies

    Benzinga | Jan. 5, 2015 | 19:11PM EST
  50. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
Trading Center